Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow A correction has been published
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Creus, M.
Right arrow Articles by Balasch, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Creus, M.
Right arrow Articles by Balasch, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 7, 1347-1352, July 2001
© 2001 European Society of Human Reproduction and Embryology

Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation

Montserrat Creus1, Jaume Ordi2, Francisco Fábregues1, Roser Casamitjana3, Juan A. Vanrell1 and Juan Balasch1,4

1 Institut Clinic of Obstetrics and Gynaecology, 2 Department of Pathology and 3 Hormonal Laboratory, Faculty of Medicine, University of Barcelona, Hospital Clínic – Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

BACKGROUND: Recent studies have indicated that the corpus luteum is a major source of circulating inhibin-A and serum concentrations of inhibin-A may reflect the human luteal function. The present prospective study was undertaken to determine the usefulness of mid-luteal serum concentrations of inhibin-A as markers of endometrial receptivity (as assessed by histological dating and {alpha}vß3 integrin expression) and whether they are better predictors of endometrial function than serum progesterone. METHODS: Consecutive infertile women (experimental group, n = 50) with regular menstrual cycles, and fertile women who were requesting contraception and had regular menstrual patterns and normal secretory endometria (control group, n = 10) were included. In all women basal body temperature, luteal serum concentrations of oestradiol, progesterone, prolactin, and inhibin-A, and endometrial biopsies were used in the same cycle to assess luteal function. RESULTS: Out-of-phase mid-secretory endometria were detected in 17 of the 50 infertile women. Lack of {alpha}vß3 integrin expression was detected in 27 of the 50 mid-luteal endometrial biopsies. Thus, hormonal concentrations were compared in the mid-luteal phase between the following eight groups of women: group 1 (n = 10), control fertile women; group 2 (n = 50), infertile women (all); subdivided into group 3 (n = 33), with in-phase biopsies; group 4 (n = 17), with out-of-phase endometria; group 5 (n = 23), expressing {alpha}vß3 integrin in endometria; group 6 (n = 27), whose endometria did not express {alpha}vß3 integrin; group 7 (n = 18), with both in-phase endometrial biopsy and {alpha}vß3 integrin expression; and finally group 8 (n = 12), whose endometria were out-of-phase and did not express {alpha}vß3 integrin. Mid-luteal serum concentrations of oestradiol, progesterone, prolactin, and inhibin-A of the seven infertile groups were similar to those of the control group of fertile women. No statistically significant difference between the infertile groups was observed for any hormonal parameter considered. CONCLUSION: Mid-luteal serum inhibin-A determination does not accurately reflect endometrial function/maturation and it is not a better indicator of endometrial luteal phase dysfunction than mid-luteal serum progesterone.

Key words: endometrium/luteal function/serum inhibin-A/serum progesterone

4 To whom correspondence should be addressed at: Institut Clinic of Obstetrics and Gynaecology, Hospital Clínic i Provincial,c/Casanova 143, 08036-Barcelona, Spain. E-mail: jbalasch{at}medicina.ub.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
A. P. Ponnampalam, G. C. Weston, A. C. Trajstman, B. Susil, and P. A.W. Rogers
Molecular classification of human endometrial cycle stages by transcriptional profiling
Mol. Hum. Reprod., December 1, 2004; 10(12): 879 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Ordi, M. Creus, L. Quinto, R. Casamitjana, A. Cardesa, and J. Balasch
Within-Subject Between-Cycle Variability of Histological Dating, {alpha}v{beta}3 Integrin Expression, and Pinopod Formation in the Human Endometrium
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2119 - 2125.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, F. Carmona, A. Cardesa, J. A. Vanrell, and J. Balasch
The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study
Hum. Reprod., April 1, 2003; 18(4): 683 - 693.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, B. Ferrer, E. Coll, J. A. Vanrell, and J. Balasch
{alpha}v{beta}3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women
Hum. Reprod., September 1, 2002; 17(9): 2279 - 2286.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.